Physician profile
Patrick M Irwin
NPI 1326481128
$6,230.52
in general payments reported to CMS, 2019-2025
42 companies · $1,990 in 2025
The $1,990 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $686 · 2020: $294 · 2021: $833 · 2022: $982 · 2023: $627 · 2024: $819 · 2025: $1,990.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,385 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Education: $50.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,385.21 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Education | $50.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,147.90 | 2019-2025 | Axonics, Lumenis Pulse 120h |
| Avyxa Pharma, LLC | $1,000.00 | 2025 | |
| Astellas Pharma US INC | $472.02 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $405.91 | 2020-2025 | Carvykti, Rybrevant, Erleada |
| Dendreon Pharmaceuticals LLC | $385.63 | 2019-2025 | Provenge |
| Medtronic, INC. | $378.27 | 2021-2025 | Interstim, Altaviva |
| Bayer Healthcare Pharmaceuticals INC. | $246.62 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $160.89 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $134.06 | 2019-2024 | |
| Genzyme Corporation | $121.78 | 2022 | |
| Ferring Pharmaceuticals INC. | $115.18 | 2019-2025 | Adstiladrin |
| Urogen Pharma, INC. | $112.53 | 2022-2025 | |
| Antares Pharma, INC. | $109.41 | 2021-2025 | Xyosted |
| Axonics, INC. | $108.56 | 2024 | Axonics, Bulkamid |
| Karl Storz Endoscopy-America | $95.34 | 2019 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $93.17 | 2021 | |
| Pfizer INC. | $88.42 | 2020-2024 | |
| Blue Earth Diagnostics | $87.03 | 2021-2025 | Posluma |
| Verity Pharmaceuticals INC. | $85.22 | 2023-2025 | Trelstar |
| Teleflex LLC | $78.31 | 2021-2025 | Urolift |
| Tolmar, INC. | $74.17 | 2023-2024 | |
| Convatec INC. | $73.31 | 2022-2023 | |
| Srs Medical Systems, INC. | $72.72 | 2020-2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Endo Pharmaceuticals INC. | $54.32 | 2020-2023 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $54.28 | 2020-2025 | Imfinzi |
| Biotissue Holdings INC. | $45.73 | 2024-2025 | |
| Accord Healthcare, INC. | $44.49 | 2022-2023 | |
| Amgen INC. | $39.04 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $38.33 | 2021-2022 | |
| Clarus Therapeutics INC. | $37.10 | 2021 | |
| Progenics Pharmaceuticals, INC. | $33.62 | 2023-2024 | Pylarify |
| Janssen Scientific Affairs, LLC | $30.75 | 2019 | |
| Olympus America INC. | $30.62 | 2023-2025 | Itind System |
| Myriad Genetic Laboratories, INC. | $28.16 | 2023 | Prolaris |
| Telix Pharmaceuticals | $26.89 | 2024 | Illuccix |
| Baxter Healthcare | $22.38 | 2023 | Tisseel |
| Dentsply Ih INC. | $18.57 | 2020 | |
| Endo USA, INC. | $18.48 | 2025 | Xiaflex |
| Ethicon US, LLC | $16.67 | 2022 | |
| Dornier Medtech America, INC | $16.06 | 2019 | |
| Urovant Sciences INC | $14.63 | 2022 | |
| Laborie Medical Technologies Corp. | $13.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Irwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.